DHIL $158.29 -0.0063%
PHI.L $536.00 -0.9242%
FLUX $3.58 -10.5%
KFYP $24.35 -1.2571%
PCT.NZ $1.23 -0.4049%
BSE.L $9.45 -5.5%
FRTA $24.00 0%
BSBK $8.12 -1.4563%
8295.HK $0.07 -8.1081%
BB $5.00 -2.7626%
0JPH.L $29.14 0.5799%
BAB.L $312.00 -0.4467%
BSBE $23.82 0%
INFE.PA $50.00 0%
ILTB $52.88 -0.5641%
CEG.L $0.10 0%
ACHC $71.11 -0.4062%
DBRT $26.36 0%
8155.HK $0.01 0%
POSI3.SA $6.66 -16.75%
GDST $10.43 0.096%
0W19.L $61.40 0.9767%
SJPY.L $73.64 0.4159%
0A26.L $12.23 0.5759%
0UC0.L $3.62 -1.0929%
TAEE11.SA $37.34 0.7284%
DBRG-PI $18.91 -0.3951%
PINC $26.90 -0.4073%
VNRG.L $80.28 0.4856%
0AH3.L $38.83 4.6468%
BRPMU $13.45 0%
PDL.L $67.40 -0.59%
1931.HK $1.59 -3.0488%
CE9G.L $22 855.00 0%
CLTL $105.62 -0.0095%
MKEA.PA $0.60 -3.0498%
0KGH.L $264.50 -0.0679%
0ROQ.L $236.75 0.6601%
WTE.L $2.20 -2.2222%
CHII $13.00 -2.8059%
6839.HK $0.30 -1.6667%
RE.PA $119.50 0.4202%
GEPA4.SA $24.99 -0.04%
INVR.L $500.50 0%
FNTS.PA $5.15 0%
CWEU.L $402.93 0%
1180.HK $0.88 -1.1236%
SGMO $1.32 1.5385%
RBCAA $39.09 -2.543%
IBUY $40.98 -2.0815%
FQAL $46.98 -0.5432%
0149.HK $0.09 0%
3789.HK $0.10 0%
KCCB $37.88 36.2679%
CAS.PA $7.51 0%
KLDW $39.70 -0.2172%
0339.HK $0.12 0%
1773.HK $2.07 4.0201%
0RH3.L $3.61 0%
IDW $0.44 -0.2258%
JIB $42.89 0%
YY $29.33 -0.8621%
PL $4.10 0.8621%
HIGA-UN $10.04 0%
GOVU.L $50.19 0.274739%
0643.HK $1.16 -6.4516%
IGTAU $10.14 0%
0R00.L $60.75 0%
DFH $16.32 -1.982%
0HSU.L $24.93 -0.1082%
RJZ $9.80 0%
VIRI $1.10 2.7944%
OMAB $87.73 -0.148%
GIL $30.52 1.0262%
HEAL.L $7.54 -0.0994%
TAIT $3.61 0.5014%
0055.HK $0.29 -1.6949%
TPHE $22.93 0.0659%
JFEN3.SA $2.37 -1.25%
XMLD.L $40.42 0.4848%
VRLA.PA $35.74 -0.3902%
MMLP $2.27 -5.6083%
AEFC $20.57 -0.2908%
FLIC $9.76 -2.2044%
MEH.PA $26.95 -1.4808%
KAIRU $10.06 0%
TCACU $8.70 0%
WIRE $162.08 -1.305%
STR $24.70 0.652%
QLYS $114.15 -0.6008%
1833.HK $18.44 -1.179%
8308.HK $0.24 0%
JW-A $53.03 0%
ALMAS.PA $0.05 -1.2397%
6090.HK $2.13 0%
ARML3.SA $11.94 4.645%
MLABO.PA $0.96 0%
1621.HK $0.09 -1.0753%
LITT $10.22 -0.0489%
2159.HK $0.98 1.0309%
Eng
Логотип
Eng
Лого

ASLAN Pharmaceuticals Limited ASLN

$4.36

-$0.15 (-3.54%)
На 18:01, 12 мая 2023

+26.15%

Потенциал через год

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    73889344.00000000

  • week52high

    4.95

  • week52low

    1.71

  • Revenue

    0

  • P/E TTM

    -1

  • Beta

    1.81579800

  • EPS

    -3.71000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    28 апр 2023 г. в 11:00

Описание компании

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.
Grading company New grade Previous grade Recommendation date
HC Wainwright & Co. Buy Buy 15 авг 2022 г.
Piper Sandler Overweight Overweight 23 мая 2022 г.
Jefferies Buy 09 июл 2021 г.
HC Wainwright & Co. Buy Buy 17 мар 2021 г.
H.C. Wainwright Buy 10 дек 2019 г.
Piper Sandler Overweight Overweight 16 сент 2022 г.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек

Новостная лента
компании

  • Изображение

    Is ASLAN Pharmaceuticals (ASLN) Stock Outpacing Its Medical Peers This Year?

    Zacks Investment Research

    27 апр 2023 г. в 11:27

    Here is how ASLAN Pharmaceuticals Ltd. (ASLN) and Sanofi (SNY) have performed compared to their sector so far this year.

  • Изображение

    Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?

    Zacks Investment Research

    05 апр 2023 г. в 11:26

    Here is how ASLAN Pharmaceuticals Ltd. (ASLN) and Atreca, Inc. (BCEL) have performed compared to their sector so far this year.

  • Изображение

    Bears are Losing Control Over ASLAN Pharmaceuticals Ltd. (ASLN), Here's Why It's a 'Buy' Now

    Zacks Investment Research

    09 мар 2023 г. в 11:25

    ASLAN Pharmaceuticals Ltd. (ASLN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately.

  • Изображение

    Is ASLAN Pharmaceuticals (ASLN) Stock Outpacing Its Medical Peers This Year?

    Zacks Investment Research

    02 мар 2023 г. в 11:18

    Here is how ASLAN Pharmaceuticals Ltd. (ASLN) and Aspira (AWH) have performed compared to their sector so far this year.

  • Изображение

    ASLAN Pharmaceuticals Announces Participation in January Investor Conferences

    GlobeNewsWire

    16 дек 2022 г. в 07:00

    SAN MATEO, Calif. and SINGAPORE, Dec. 16, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the Company's participation in upcoming conferences for January 2023. Listed below are meetings that management will be attending around the week of the J.P. Morgan 41st Annual Healthcare Conference.